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a  b  s  t  r  a  c  t
INTRODUCTION:  Gastrointestinal  stromal  tumor  (GIST)  is  the  commonest  mesenchymal  tumor  of  GI  tract
and 60–70%  of  it  seen  in the stomach,  whereas  Gastric  schwannoma  is  a benign,  slow  growing  and  one
of  the rare neoplasms  of  stomach.  Age  distribution,  clinical,  radiological  features  and  gross  appearance
of  both  tumors  are  similar.
PRESENTATION  OF  CASE:  We  report  a rare  case  of  gastric  schwannoma  in  a 20-year-old  girl, who  under-
went  subtotal  gastrectomy  with  the  suspicion  of a GIST  preoperatively  but  later  conﬁrmed  to  be  gastric
schwannoma  postoperatively  after  immunohistochemical  study.
DISCUSSION:  Accordingly,  the  differential  diagnosis  for gastric  submucosal  mass  should  be  gastric
schwannoma.  Furthermore,  Gastric  schwannoma  is  a benign  neoplasm  with  excellent  prognosis  after
surgical  resection,  whereas  10–30%  of  GIST  has  malignant  behavior.  Therefore,  it is important  to distin-
guish  between  gastric  schwannoma  and  GIST  so  as  to  make  an  accurate  diagnosis  for optimally  guide
treatment  options.
CONCLUSION:  Due  to the  paucity  of gastric  schwannoma,  the  index  of suspicion  for this  diagnosis  is  low.
So  it  is  important  to include  gastric  schwannoma  in  the  differential  diagnosis  when  preoperative  imaging
studies  reveal  submucosal  exophytic  gastric  mass  and  after resection  of  the  tumor  with  a negative  margin,
it should  be  sent  for  immunohistochemical  study  for  conﬁrmation  of  diagnosis.
©  2016  The  Author(s).  Published  by Elsevier  Ltd on behalf  of  IJS Publishing  Group  Ltd.  This  is  an  open
he CCaccess  article  under  t
. Introduction
Both Gastrointestinal stromal tumor (GIST) and Schwannoma
elong to the family of mesenchymal tumors of gastrointestinal
ract [1]. Among these neoplasms, GIST is the commonest and
0–70% of it seen in the stomach [2,3]. Schwannoma is one of the
are neoplasms of GI tract and stomach is the most common site,
ccounting for only 0.2% of all gastric tumors and 4% of all benign
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gastric neoplsms [4]. Accordingly, both are taken as differential
diagnosis for each other.
2. Case report
A 20-year-old female presented with symptoms of dyspepsia
like early satiety, fullness of stomach after taking small meal and
heart burn for last six months. Two months later she noticed a lump
in the upper abdomen which was not associated with pain or vomit-
ing. There was  no other signiﬁcant past medical or surgical history.
On examination she was mild pallor, with a ﬁrm, non tender lump
of size 6cm × 5 cm present in the epigastrium having ill deﬁned
margin, uneven surface and moving with respiration. Rest of the
abdomen was  normal.Ultrasonography (USG) of the abdomen revealed a well deﬁned
heterogeneously hypoechoiec SOL measuring 6.1cm × 5.8 cm with
internal vascularity posterior to body of stomach suggestive of
Gastrointestinal Stromal Tumor (GIST). USG guided FNAC of the
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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mig. 1. Contrast enhanced CT scan of the abdomen showing intensely enhancing 
urvature of stomach.
esion revealed sheets of neoplastic cells over a hemorrhagic
ackground suggestive of GIST. Upper GI Endoscopy was nor-
al  except for a healed duodenal ulcer scar. Contrast enhanced
T scan of the abdomen revealed intensely enhancing hetero-
eneous, well deﬁned, rounded, exophytic soft tissue lesion of
ize 7cm × 6.2cm × 8 cm arising from greater curvature of stomach
butting the pancreas and superior mesenteric vein, possibly GIST
Fig. 1). So a pre op diagnosis, “Gastric GIST” was made on the basis
f clinical and radiological ﬁnding and the patient was taken up for
urgery.
With the patient in supine position the abdomen was  opened
hrough an upper-midline incision. We  proceeded into the lesser
ac after dividing the gastrocolic omentum and the pathol-
gy identiﬁed. An exophytic growth of size approximately
cm × 6cm × 8 cm present involving the body and antrum of the
tomach nearer to the greater curvature, which was  ﬁrm in con-
istency and having a nodular surface (Fig. 2). Then the stomach
as mobilized and a subtotal gastrectomy with omentectomy
one followed by antecolic, antiperistaltic gastro-jejunostomy and
ejuno-jejunostomy. The cut section of the tumor revealed yel-
owish white, solid, homogeneous surface (Fig. 3). The resected
pecimen sent for histopathological study.
The post operative period was uneventful and she discharged
n 10th post op day. During the follow up after 3 months, she was
bsolutely asymptomatic.
The ﬁnal pathological study revealed that the resected tumor
ass was arising from the layers of stomach with submucosal
Fig. 2. Intra operative photograph of the exophytic growth involving the body and
antrum of the stomach nearer to the greater curvature, having a nodular surface.
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Fig. 3. Resected omentum and subtotal gastrectomy specimen with the nodular
growth which on cut section having a solid, homogenous and yellowish white sur-
face.


















cal  collagenisation and having peripheral cuff of lymphoid cells (arrow). (H&E × 40).
:  Spindle cells having plump to slender nuclei, mild nuclear atypia and eosinophilic
ytoplasm with stromal collagenisation. (H&E × 100).
roliferation of spindle cells with interlacing and curling bundles
ith plump to slender nuclei, mild nuclear atypia and eosinophilic
ytoplasm with stromal collagenisation (Fig. 4B). The tumor cell
est showed peripheral cuff of lymphoid cells (Fig. 4A) as well as
cattered lymphocytes and plasma cells. There was  sparse mitotic
ctivity (<5/50 HPF). The tumor cells were immunoreactive with
100 protein (Fig. 5A), but lack of immunoreactivity with CD117
Fig. 5B). So the histopathological features and immunohistochem-
cal staining pattern were consistent with Gastric Schwannoma
nstead of GIST.
. Discussion
Gastrointestinal (GI) mesenchymal tumors consist mainly a
pectrum of spindle cell tumors which include gastrointestinal
tromal tumors (GISTs), leiomyomas or leiomyosarcomas, and
chwannomas [1]. Among these neoplasms, GISTs are the most
ommon and 60–70% of them seen in the stomach [2,3]. Schwanno-Fig. 5. A: Immunohistochemical study of tumor cells showing strong S100 positiv-
ity.  B: Immunohistochemical study of tumor cells showing CD117 (c-kit) negativity.
mas  are benign, slow-growing, encapsulated nerve-sheath tumors
arising from schwann cells, meant for the myelin sheath formation
in the peripheral nervous system. They can occur anywhere along
the course of the peripheral nerve, but commonly it occurs in the
head and neck region, rarely in the GI tract [5]. Gastrointestinal
schwannomas are usually non-encapsulated, but well demarcated
tumors [6]. Within the GI tract stomach is the most common site for
schwannoma accounting for only 0.2% of all gastric tumors and 4%
of all benign gastric neoplsms [4]. Gastric schwannomas are usually
intramural (65%), but they can be intraluminal or subserosal. The
tumors arise most commonly from the body of the stomach (50%)
followed by the antrum (32%) and the fundus (18%) [7].
Gastric Schwannomas occur more frequently in the ﬁfth to sixth
decades of life with a female predominance [8,9]. They are often
asymptomatic and can be discovered incidentally through upper
GI endoscopy or cross-sectional imaging. The most common pre-
senting symptom is an episode of upper GI bleeding, secondary to
the growing submucosal mass compromising the blood supply to
the overlying mucosa followed by ulceration secondary to ischemia
or from a reduced tolerance to the gastric acidity [4,5]. Presence of
a submucosal intra luminal mass near the pylorus may  cause gas-
tric outlet obstruction. If the tumor shows exophytic growth, then
patient may  present with a palpable epigastric mass [10], as in our
case.
Diagnostic modalities include upper GI endoscopy, computed
tomography (CT) scan, magnetic resonance imaging (MRI), ultra-
sonography, endoluminal ultrasonography (EUS) and upper gastro
intestinal barium study. But all these investigations provide only
limited information about the tumor. The deﬁnitive diagnosis of
gastric schwannoma is determined only after histopathological and
immunohistochemical examination [8]. Endoscopy helps to deﬁne
the exact location of intraluminal submucosal tumors. Endoscopic
needle biopsy is useful to establish a deﬁnite diagnosis of a submu-
cosal tumor, but GISTs are having theoretical risk of hemorrhage
or tumor rupture which is associated with poor prognosis [11].
On contrast enhanced CT scan, in contrast to GIST, gastric schwan-
nomas appear mostly as homogenous, strongly contrast-enhanced
tumors without signs of hemorrhage, necrosis, cystic changes or
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alciﬁcation [12]. MRI  provides further information about the exact
ocation of the tumor and its relation to the surrounding structures.
astric shwannomas appear on MRI  as strongly enhancing tumors.
n T1 weighted images, they have low to medium signal intensity
hereas high signal intensity on T2 weighted Images [13]. EUS is
seful for visualizing the submucosal lesions of the stomach. The
ndosonographic features of schwannomas include homogeneous
ypoechoic internal echoes with a marginal halo corresponding
o the peritumoral lymphoid cuff in histopathological examination
14]. Transabdominal ultrasonography is helpful for larger tumors.
SG-guided percutaneous core biopsy is also one of the possible
ethod to obtain a precise preoperative diagnosis [7].
The typical histologic features of gastric schwannoma are pro-
iferated spindle cells usually arranged in interlacing and curling
undles and presence of peritumoral lymphoid cuff [15,16], as in
ur case. Gastric schwannoma differs histologically from other soft
issue schwannoma by absence of capsulation and rarity of nuclear
alisading, xanthoma cells, vascular hyalinization and dilatation
15]. The histology of gastric schwannomas is similar to other mes-
nchymal tumours such as GIST, leiomyoma and leiomyosarcoma
nd these can be differentiated by the aid of Immunohistochem-
cal (IHC) staining. Positive desmin and smooth muscle actin
tains indicate leiomyoma or leiomyosarcoma, positive CD34 and
D117 (c-kit) indicate GIST and positive S100 indicate Schwan-
oma [1,2,15,16]. Thus, in our case, the positivity for S100 and
egativity for CD117 marker conﬁrmed the diagnosis of Gastric
chwannoma.
Surgical resection is considered as the treatment of choice in
atients with gastric schwannoma. Depending upon the size, loca-
ion and surrounding involvement of the tumor local extirpation,
edge resection, partial, subtotal or even total gastrectomy are
cceptable surgical procedures with a low recurrence rate [17].
owadays laparoscopic techniques are also used [18].
Both gastric schwannomas and gastric GISTs are similar in age
f occurrence, clinical features, gross and histological appearance.
ut they differ in prognosis [1,2,4,8,9,16]. The former is having an
xcellent prognosis [6,8,9], whereas 10–30% of GISTs are malignant
1,2,19]. As most of the diagnostic modalities cannot always provide
nough information to differentiate between these two tumors,
ltimately the deﬁnitive diagnoses of GISTs and gastric schwan-
omas require immunohistochemical studies which only can be
erformed on the surgical specimen.
. Conclusion
Though gastric schwannoma is a rare tumor of stomach, it
s important that we should consider it in the differential diag-
osis when preoperative imaging studies reveal a submucosal
xophytic gastric mass. According to most of the literatures it is
 slow growing benign neoplasm and in contrast to GIST, rarely
ndergoes malignant transformation and has a good prognosis.
o every submucosal mass lesion of the stomach should be sent
or histopathology and immunohistochemical study after complete
argin negative surgical resection for conﬁrmation of diagnosis
nd further planning of treatment.
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